...
首页> 外文期刊>Journal of atherosclerosis and thrombosis. >Thyroid Function Influences Serum Apolipoprotein B-48 Levels in Patients with Thyroid Disease
【24h】

Thyroid Function Influences Serum Apolipoprotein B-48 Levels in Patients with Thyroid Disease

机译:甲状腺功能影响甲状腺疾病患者血清载脂蛋白B-48水平

获取原文
           

摘要

Aim: Apolipoprotein B-48 (apoB-48) is a major apolipoprotein of intestine-derived chylomicrons (CM) and CM remnants (CMR). Clinically overt hypothyroidism (OH) has been associated with premature and accelerated coronary atherosclerosis. To clarify the clinical significance of apoB-48 measurement in patients with thyroid disease, we investigated the correlations between the serum apoB-48 level and thyroid hormones. Methods: From outpatients of Osaka University Hospital, patients with OH, subjects with subclinical hypothyroidism (SH) and subjects with normal thyroid function were collected and analyzed by measuring serum TSH, FT4 and FT3 levels. Serum apoB-48 levels were measured by a chemiluminescence enzyme immunoassay and the correlations with thyroid hormone levels or lipid profiles were assessed. These levels were compared among subjects with OH, SH and healthy controls. Results: Serum apoB-48 level was correlated with TSH, total cholesterol (TC) and triglycerides (TG), but negatively with FT4 and FT3 level. LDL-C and HDL-C levels were not correlated with serum apoB-48 levels. Serum apoB-48 in patients with OH (7.4±5.9μg/mL) was significantly higher than in those with hyperthyroidism (5.1±3.5μg/mL; p <0.01) and normal subjects (4.7±3.7μg/mL; p <0.01), but decreased after levo-thyroxine replacement. ApoB-48, TG and TSH were significantly higher in SH subjects than normal subjects, suggesting that serum apoB-48 level depends on the thyroid function status, similar to TC, LDL-C and TG. Conclusion: Increased serum apoB-48 concentrations and CMR may contribute to the increased risk of atherosclerosis and premature coronary artery disease in the hypothyroid state.
机译:目的:载脂蛋白B-48(apoB-48)是肠源性乳糜微粒(CM)和CM残留物(CMR)的主要载脂蛋白。临床上明显的甲状腺功能减退症(OH)与过早和加速的冠状动脉粥样硬化有关。为了阐明apoB-48检测在甲状腺疾病患者中的临床意义,我们调查了血清apoB-48水平与甲状腺激素之间的相关性。方法:从大阪大学医院的门诊患者中,收集OH患者,亚临床甲状腺功能减退症(SH)患者和甲状腺功能正常的患者,并通过测量血清TSH,FT4和FT3水平进行分析。通过化学发光酶免疫测定法测量血清apoB-48水平,并评估与甲状腺激素水平或脂质谱的相关性。在患有OH,SH和健康对照组的受试者中比较了这些水平。结果:血清apoB-48水平与TSH,总胆固醇(TC)和甘油三酸酯(TG)相关,而与FT4和FT3水平呈负相关。 LDL-C和HDL-C水平与血清​​apoB-48水平无关。 OH患者(7.4±5.9μg/ mL)的血清apoB-48明显高于甲亢患者(5.1±3.5μg/ mL; p <0.01)和正常人(4.7±3.7μg/ mL; p <0.01) ),但在左甲状腺素替代后下降。 SH受试者中ApoB-48,TG和TSH显着高于正常受试者,这表明血清apoB-48水平取决于甲状腺功能状态,与TC,LDL-C和TG相似。结论:升高的血清apoB-48浓度和CMR可能导致甲状腺功能减退状态下的动脉粥样硬化和早发冠状动脉疾病的风险增加。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号